Description

You will lead the global lifecycle strategy for a promising RAS inhibitor in lung cancer, driving the program from pivotal development through commercialization and post-launch expansion. This role involves defining the strategic roadmap, integrating cross-functional teams, and ensuring alignment across clinical, regulatory, and commercial functions to maximize patient and enterprise value.

Requirements

• Bachelor's degree required, MBA or advanced degree preferred
• 15+ years of biopharmaceutical experience with significant oncology commercialization leadership
• Demonstrated success leading at least one global NME launch in oncology
• Deep expertise in lifecycle management, brand strategy, global marketing, and market access
• Proven experience in multifunctional, high-pressure environments with ambitious milestones

Responsibilities

• Define and refine global lifecycle strategy for daraxonrasib across indications and combinations
• Translate clinical data and competitive insights into differentiated commercial positioning
• Lead cross-functional Lifecycle Team and working groups to ensure integrated decision-making
• Develop and own strategic roadmap, milestones, financial targets, and key objectives
• Build, lead, and develop a high-performing lifecycle team and contribute to function maturation